The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy

Health and Quality of Life Outcomes

Volumn 6, Issue , 2008, Pages

  Matza, Louis S ^a   Rousculp, Matthew D ^b   Malley, Karen ^c   Boye, Kristina S ^b   Oglesby, Alan ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Malley Research Programming Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRIVING ABILITY; EYE PAIN; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; VISUAL ACUITY; VISUAL FUNCTION QUESTIONNAIRE; VISUAL IMPAIRMENT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH STATUS; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ENZYME INHIBITOR; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; RUBOXISTAURIN;

AGED; DIABETIC RETINOPATHY; ENZYME INHIBITORS; FEMALE; HEALTH STATUS; HUMANS; INDOLES; LONGITUDINAL STUDIES; MALE; MALEIMIDES; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES; VISUAL ACUITY;

EID: 58149347333     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-6-95     Document Type: Article

References (44)

1. Fong DS Aiello LP Ferris FL 3rd Klein R Diabetic retinopathy Diabetes Care 2004, 27(10):2540-2553 10.2337/diacare.27.10.2540 15451934
2. Frank RN Diabetic retinopathy N Engl J Med 2004, 350(1):48-58 10.1056/ NEJMra021678 14702427
3. The Eye Diseases Prevalence Research Group The prevalence of diabetic retinopathy among adults in the United States Arch Ophthalmol 2004, 122(4):552-563 10.1001/archopht.122.4.552 15078674
4. Klein R Klein BE Relation of glycemic control to diabetic complications and health outcomes Diabetes Care 1998, 21(Suppl 3):C39-43 9850488
5. Schrier RW Estacio RO Esler A Mehler P Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes Kidney Int 2002, 61(3):1086-1097 10.1046/j.1523-1755.2002.00213.x 11849464
6. Stratton IM Kohner EM Aldington SJ Turner RC Holman RR Manley SE Matthews DR UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis Diabetologia 2001, 44(2):156-163 10.1007/s001250051594 11270671
7. The Diabetes Control and Complications Trial (DCCT) Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993, 329(14):977-986 10.1056/NEJM199309303291401 8366922
8. UK Prospective Diabetes Study (UKPDS) Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 1998, 317(7160):703-713 28659 9732337
9. Roy MS Klein R O'Colmain BJ Klein BE Moss SE Kempen JH The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States Arch Ophthalmol 2004, 122(4):546-551 10.1001/archopht.122.4.546 15078673
10. Williams R Airey M Baxter H Forrester J Kennedy-Martin T Girach A Epidemiology of diabetic retinopathy and macular oedema: A systematic review Eye 2004, 18(10):963-983 10.1038/sj.eye.6701476 15232600
11. Coyne KS Margolis MK Kennedy-Martin T Baker TM Klein R Paul MD Revicki DA The impact of diabetic retinopathy: Perspectives from patient focus groups Fam Pract 2004, 21(4):447-453 10.1093/fampra/cmh417 15249536
12. Woodcock A Bradley C Plowright R Ffytche T Kennedy-Martin T Hirsch A The influence of diabetic retinopathy on quality of life: Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL Patient Educ Couns 2004, 53(3):365-383 10.1016/ j.pec.2003.10.007 15186876
13. Knudtson MD Klein BE Klein R Cruickshanks KJ Lee KE Age-related eye disease, quality of life, and functional activity Arch Ophthalmol 2005, 123(6):807-814 10.1001/archopht.123.6.807 15955982
14. Sharma S Oliver-Fernandez A Bakal J Hollands H Brown GC Brown MM Utilities associated with diabetic retinopathy: Results from a Canadian sample Br J Ophthalmol 2003, 87(3):259-261 1771570 12598432 10.1136/ bjo.87.3.259
15. Sharma S Oliver-Fernandez A Liu W Buchholz P Walt J The impact of diabetic retinopathy on health-related quality of life Curr Opin Ophthalmol 2005, 16(3):155-159 10.1097/01.icu.0000161227.21797.3d 15870571
16. Tung TH Chen SJ Lee FL Liu JH Lin CH Chou P A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan Diabetes Res Clin Pract 2005, 68(3):265-273 10.1016/j.diabres.2004.10.003 15936470
17. Brown MM Brown GC Sharma S Landy J Bakal J Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration Arch Ophthalmol 2002, 120(4):481-484 11934322
18. Clarke PM Simon J Cull CA Holman RR Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36 Diabetes Care 2006, 29(7):1506-1511 10.2337/dc05-2150 16801570
19. Klein R Moss SE Klein BE Gutierrez P Mangione CM The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: The Wisconsin epidemiologic study of diabetic retinopathy Arch Ophthalmol 2001, 119(5):733-740 11346401
20. Globe DR Wu J Azen SP Varma R The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino eye study Ophthalmology 2004, 111(6):1141-1149 10.1016/j.ophtha.2004.02.003 15177964
21. Nirmalan PK Tielsch JM Katz J Thulasiraj RD Krishnadas R Ramakrishnan R Robin AL Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: The Aravind comprehensive eye survey Invest Ophthalmol Vis Sci 2005, 46(7):2308-2312 10.1167/iovs.04-0830 15980215
22. PKC-DRS2 Group Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy Ophthalmology 2006, 113(12):2221-2230 10.1016/ j.ophtha.2006.07.032 16989901
23. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1 Arch Ophthalmol 1985, 103(12):1796-1806 2866759
24. Mangione CM Lee PP Pitts J Gutierrez P Berry S Hays RD Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators Arch Ophthalmol 1998, 116(11):1496-1504 9823352
25. Mangione CM Lee PP Gutierrez PR Spritzer K Berry S Hays RD Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 2001, 119(7):1050-1058 11448327
26. Cahill MT Banks AD Stinnett SS Toth CA Vision-related quality of life in patients with bilateral severe age-related macular degeneration Ophthalmology 2005, 112(1):152-158 10.1016/j.ophtha.2004.06.036 15629836
27. Deramo VA Cox TA Syed AB Lee PP Fekrat S Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 2003, 121(9):1297-1302 10.1001/archopht.121.9.1297 12963613
28. Globe DR Varma R Torres M Wu J Klein R Azen SP Self-reported comorbidities and visual function in a population-based study: The Los Angeles Latino eye study Arch Ophthalmol 2005, 123(6):815-821 10.1001/ archopht.123.6.815 15955983
29. Ma SL Shea JA Galetta SL Jacobs DA Markowitz CE Maguire MG Balcer LJ Self-reported visual dysfunction in multiple sclerosis: New data from the VFQ-25 and development of an MS-specific vision questionnaire Am J Ophthalmol 2002, 133(5):686-692 10.1016/S0002-9394(02)01337-5 11992867
30. Ware JE Jr Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992, 30(6):473-483 10.1097/00005650-199206000-00002 1593914
31. Ware JE Jr Snow KK Kosinski M Gandek B SF-36 Health Survey: Manual and Interpretation Guide Boston: The Health Institute, New England Medical Center 1993, 11-11-11
32. Rubin GS Munoz B Bandeen-Roche K West SK Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability Invest Ophthalmol Vis Sci 2000, 41(11):3327-3334 11006221
33. Cohen J Statistical power analysis for the behavioral sciences Hillsdale, NJ: Lawrence Erlbaum Associates 2 1988
34. Wulsin LR Jacobson AM Rand LI Psychosocial correlates of mild visual loss Psychosom Med 1991, 53(1):109-117 2011646
35. Toprak AB Eser E Guler C Baser FE Mayali H Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25) Ophthalmic Epidemiol 2005, 12(4):259-269 10.1080/09286580590967763 16033747
36. Kalpaklioglu AF Kara T Kurtipek E Kocyigit P Ekici A Ekici M Evaluation and impact of chronic cough: Comparison of specific vs generic quality-of-life questionnaires Ann Allergy Asthma Immunol 2005, 94(5):581-585 15945562
37. Leong KP Yeak SC Saurajen AS Mok PK Earnest A Siow JK Chee NW Yeo SB Khoo ML Lee JC Seshadri R Chan SP Tang CY Chng HH Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis Clin Exp Allergy 2005, 35(3):288-298 10.1111/j.1365-2222.2005.02201.x 15784105
38. Wiebe S Guyatt G Weaver B Matijevic S Sidwell C Comparative responsiveness of generic and specific quality-of-life instruments J Clin Epidemiol 2003, 56(1):52-60 10.1016/S0895-4356(02)00537-1 12589870
39. Coons SJ Rao S Keininger DL Hays RD A comparative review of generic quality-of-life instruments Pharmacoeconomics 2000, 17(1):13-35 10.2165/ 00019053-200017010-00002 10747763
40. Graue M Wentzel-Larsen T Hanestad BR Batsvik B Sovik O Measuring self-reported, health-related, quality of life in adolescents with type 1 diabetes using both generic and disease-specific instruments Acta Paediatr 2003, 92(10):1190-1196 10.1080/08035250310005657 14632337
41. Guyatt GH Feeny DH Patrick DL Measuring health-related quality of life Ann Intern Med 1993, 118(8):622-629 8452328
42. Kaplan RM Groessl EJ Sengupta N Sieber WJ Ganiats TG Comparison of measured utility scores and imputed scores from the SF-36 in patients with rheumatoid arthritis Med Care 2005, 43(1):79-87 15626937
43. Leidy NK Revicki DA Geneste B Recommendations for evaluating the validity of quality of life claims for labeling and promotion Value in Health 1999, 2(2):113-127 10.1046/j.1524-4733.1999.02210.x 16674343
44. Neumann PJ Goldie SJ Weinstein MC Preference-based measures in economic evaluation in health care Annu Rev Public Health 2000, 21:587-611 10.1146/annurev.publhealth.21.1.587 10884966